A glucose test calculates cardiovascular risk in people without diabetes


The leading cause of death worldwide is due to cardiovascular problems. But a new discovery can change this problem. And it is that after numerous investigations, it has been confirmed that a glucose test show the cardiovascular risk in people without diabetes. A breakthrough for world health.

According to data from the World Health Organization (WHO), cardiovascular problems such as hypertension, heart failure or vascular disease are behind a third of deaths. Given this, it is essential to find tools that allow detecting these cardiovascular problems before they manifest themselves.

Health experts always emphasize the importance of prevention in the face of this type of problem that puts our health at risk. Here are the three basic pillars: smoking cessation, healthy diet and physical activity. If this is carried out, according to calculations by the Spanish Heart Foundation and the World Heart Federation, up to a quarter of deaths would be avoided.

Therefore, to avoid this type of cardiovascular problems, this healthy lifestyle must be put into practice. In this way, a great containment barrier is achieved for atherosclerosis, which causes heart attacks.

Early detection is also very important in these aspects, since it radically changes the prognosis. In addition, it is an important value to improve the quantity and quality of years of life of the population.

Glycated hemoglobin and cardiovascular problems

From the National Center for Cardiovascular Research (CNIC) they have pointed out that glycosylated hemoglobin in non-diabetic people helps to identify those with more atherosclerosis, associated with cardiovascular problems. That is, it is used to calculate the degree of subclinical atherosclerosis (which has not yet given any symptoms) of someone.

For those who do not know it, glycated hemoglobin is an indicative biomarker of blood sugar level that is generally done for the control of diabetes. And it is that knowing the glycosylated hemoglobin supposes to refine more the possibility of presenting atherosclerosis and – ultimately – cardiovascular disease. So “reducing glycated hemoglobin levels in people without diabetes should improve cardiovascular risk.”

This is a marker that experts advise for use in healthy middle-aged individuals. In fact, how the medium picks up Feed +, when used in conjunction with traditional risk factors (hypertension, dyslipidemia, smoking), improves the classification of people with the highest and lowest risk of atherosclerotic disease.

Leave a comment

Your email address will not be published.